In cohort of individuals with diabetes, no association seen for chronic kidney disease stage 3 to 5 with atopic eczema, psoriasis
All-Cause Mortality Lower for Melanomas ID’d in Routine Skin Checks
After adjustment for prognostic factors, no association seen between detection by routine skin check and melanoma-specific mortality
Outpatient Care Has Shifted Toward More Specialist Care for Medicare Recipients
From 2000 to 2019, annual number of visits to specialists and number of unique specialists seen increased; little increase seen in PCP visits
Progression Likely With Early Diffuse Cutaneous Systemic Sclerosis
Case fatality rate high despite early use of immunosuppressive therapies
Seven Best Diagnostic Criteria ID’d for Childhood Psoriasis
Presence of two or more of these criteria has a sensitivity and specificity of more than 70 percent, the authors say
Predictors Explored for Response to UVB Phototherapy in Psoriasis
Higher body mass index and positive smoking status predict poorer phototherapy response
USPSTF Presents New Approach to Sex, Gender in Recommendations
Task force will use inclusive approach to identify issues related to sex, gender in guideline development; will use gender-neutral language
Psoriatic Arthritis May Up Risk for Preterm Birth, C-Section
Risk for preterm birth increased with antirheumatic treatment for psoriatic arthritis — particularly biologics — during pregnancy
More Than Half of COVID-19 Survivors Have Postacute Sequelae
Most common sequelae include functional mobility impairments, pulmonary abnormalities, and mental health disorders
FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
Cyltezo is first interchangeable monoclonal antibody for RA, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, chronic plaque psoriasis